About Cargo Therapeutics
Cargo Therapeutics is a company based in San Mateo (United States) founded in 2021 by Louai Labanieh, Robbie Majzner, and Nancy Goodman was acquired by Concentra Biosciences in July 2025.. Cargo Therapeutics has raised $200 million across 1 funding round from investors including Nextech Systems, T. Rowe Price and Janus Henderson Investors. The company has 42 employees as of December 31, 2022. Cargo Therapeutics offers products and services including CRG-023. Cargo Therapeutics operates in a competitive market with competitors including Senti Biosciences, Caribou Biosciences, Poseida Therapeutics, Immunocore and Juno Therapeutics, among others.
- Headquarter San Mateo, United States
- Employees 42 as on 31 Dec, 2022
- Founders Louai Labanieh, Robbie Majzner, Nancy Goodman
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cargo Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$200 M (USD)
in 1 rounds
-
Latest Funding Round
$200 M (USD), Series A
Feb 09, 2023
-
Investors
Nextech Systems
& 15 more
-
Employee Count
42
as on Dec 31, 2022
-
Acquired by
Concentra Biosciences
(Jul 08, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cargo Therapeutics
Cargo Therapeutics offers a comprehensive portfolio of products and services, including CRG-023. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for developing allogeneic CAR T-cell therapies to treat cancer.
Unlock access to complete
Funding Insights of Cargo Therapeutics
Cargo Therapeutics has successfully raised a total of $200M through 1 strategic funding round. The most recent funding activity was a Series A round of $200 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $200.0M
-
First Round
First Round
(09 Feb 2023)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2023 | Amount | Series A - Cargo Therapeutics | Valuation | Third Rock Ventures , RTW Investments |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cargo Therapeutics
Cargo Therapeutics has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include Nextech Systems, T. Rowe Price and Janus Henderson Investors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital funding is provided to early-stage life science companies.
|
Founded Year | Domain | Location | |
|
Life Sciences focused VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Multiple sectors are targeted for venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cargo Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cargo Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cargo Therapeutics Comparisons
Competitors of Cargo Therapeutics
Cargo Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Senti Biosciences, Caribou Biosciences, Poseida Therapeutics, Immunocore and Juno Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cell-based therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Provider of cell therapies to treat cancer and hematologic conditions
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
T cell-based treatments for immunological and oncological disorders are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cargo Therapeutics
Frequently Asked Questions about Cargo Therapeutics
When was Cargo Therapeutics founded?
Cargo Therapeutics was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Where is Cargo Therapeutics located?
Cargo Therapeutics is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
Is Cargo Therapeutics a funded company?
Cargo Therapeutics is a funded company, having raised a total of $200M across 1 funding round to date. The company's 1st funding round was a Series A of $200M, raised on Feb 09, 2023.
How many employees does Cargo Therapeutics have?
As of Dec 31, 2022, the latest employee count at Cargo Therapeutics is 42.
What does Cargo Therapeutics do?
Cargo Therapeutics was founded in 2021 and is based in San Mateo, United States. Focus is placed on the biotechnology sector, where cell-based therapeutics are developed for cancer treatment. CAR T-cell therapies, including CD22 CAR T and multi-specific CAR T candidates, are offered for addressing hematological malignancies and solid tumors. Operations center on advancing these drug candidates through research and development.
Who are the top competitors of Cargo Therapeutics?
Cargo Therapeutics's top competitors include Immunocore, Juno Therapeutics and Lyell Immunopharma.
What products or services does Cargo Therapeutics offer?
Cargo Therapeutics offers CRG-023.
Who are Cargo Therapeutics's investors?
Cargo Therapeutics has 16 investors. Key investors include Nextech Systems, T. Rowe Price, Janus Henderson Investors, RTW Investments, and Piper Sandler.